| Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial. | |
| | |
MedLine Citation:
|
PMID: 11529537 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONCLUSION: This study confirmed the gain in H-SDS CA in Noonan's syndrome during long-term GH treatment. However, the accelerating effect of GH on bone maturation seemed to compromise the final height prognosis. |
| | |
Authors:
|
C Noordam; I Van der Burgt; R C Sengers; H A Delemarre-van de Waal; B J Otten |
Related Documents
:
|
10443647 - Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery ... 15559337 - Ablative or excisional laparoscopic surgery for endometriotic cysts: resolving the issue. 5946547 - Achondroplastic dwarfism. effects of treatment with human growth hormone. 9007857 - Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereo... 17920887 - Introduction of a new mobile-bearing total knee prosthesis: minimum three year follow-u... 18206597 - Importance of the new radiographic sign of fecal loading in the cecum in the presence o... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: Acta paediatrica (Oslo, Norway : 1992) Volume: 90 ISSN: 0803-5253 ISO Abbreviation: Acta Paediatr. Publication Date: 2001 Aug |
Date Detail:
|
Created Date: 2001-08-31 Completed Date: 2002-01-03 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 9205968 Medline TA: Acta Paediatr Country: Norway |
Other Details:
|
Languages: eng Pagination: 889-94 Citation Subset: IM |
Affiliation:
|
Department of Paediatric Endocrinology, University Medical Centre St Radboud, Nijmegen, The Netherlands. C.Noordam@ckskg.azn.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Analysis of Variance Body Height / drug effects* Child Child, Preschool Female Growth Hormone / therapeutic use* Humans Male Noonan Syndrome / drug therapy* Prospective Studies Time Factors |
| Chemical | |
Reg. No./Substance:
|
9002-72-6/Growth Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's dis...
Next Document: The breech presentation and the vertex presentation following an external version represent risk fac...